Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) is the 1st most profitable stock in this segment of the market. Its net profit margin was 57.71% for the last 12 months. Its operating profit margin was 57.21% for the same period.
InterMune, Inc. (NASDAQ:ITMN) is the 2nd most profitable stock in this segment of the market. Its net profit margin was 47.91% for the last 12 months. Its operating profit margin was 50.28% for the same period.
Transition Therapeutics Inc. (NASDAQ:TTHI) is the 3rd most profitable stock in this segment of the market. Its net profit margin was 40.69% for the last 12 months. Its operating profit margin was 40.08% for the same period.
Techne Corporation (NASDAQ:TECH) is the 4th most profitable stock in this segment of the market. Its net profit margin was 39.16% for the last 12 months. Its operating profit margin was 57.20% for the same period.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is the 5th most profitable stock in this segment of the market. Its net profit margin was 36.58% for the last 12 months. Its operating profit margin was 36.42% for the same period.
Osiris Therapeutics, Inc. (NASDAQ:OSIR) is the 6th most profitable stock in this segment of the market. Its net profit margin was 34.90% for the last 12 months. Its operating profit margin was 33.58% for the same period.
Gilead Sciences, Inc. (NASDAQ:GILD) is the 7th most profitable stock in this segment of the market. Its net profit margin was 34.47% for the last 12 months. Its operating profit margin was 47.54% for the same period.
China Pharma Holdings, Inc. (AMEX:CPHI) is the 8th most profitable stock in this segment of the market. Its net profit margin was 31.29% for the last 12 months. Its operating profit margin was 31.92% for the same period.
SuperGen, Inc. (NASDAQ:SUPG) is the 9th most profitable stock in this segment of the market. Its net profit margin was 30.71% for the last 12 months. Its operating profit margin was 30.09% for the same period.
Amgen, Inc. (NASDAQ:AMGN) is the 10th most profitable stock in this segment of the market. Its net profit margin was 30.23% for the last 12 months. Its operating profit margin was 35.32% for the same period.
